Interim report 2018-01-01 – 2018-03-31
The Board and Chief Executive Officer of Cereno Scientific AB herewith present the interim report for the first quarter 2018. Summary of the interim reportThree months (2018-01-01 – 2018-03-31) · Net sales were 0 SEK (0 SEK). · Loss after financial items was -1 805 442 SEK (-739 403 SEK). · Loss per share was -0.16 SEK (-0.07 SEK) before dilution and -0.16 SEK (-0.07 SEK) after dilution. · Equity ratio was 88.9 % (92.6 %).Amounts in parentheses: Prior year comparative periodEquity ratio: Shareholders’ equity divided by total capitalEarnings per share: Profit/loss for